COST-EFFECTIVENESS OF PRE-TRANSPLANT SOFOSBUVIR TO PREVENT RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Vitale, A. [1 ]
Spolverato, G. [1 ]
Burra, P. [1 ]
De Feo, T. M. [2 ]
Cillo, U. [1 ]
Fagiuoli, S. [3 ]
机构：
[1] Univ Hosp Padua, Padua, Italy
[2] Fdn IRCCS Ca Granda OMP, North Italy Transplant Program, Milan, Italy
[3] Osped Papa Giovanni XXIII, Bergamo, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2015年 / 47卷
关键词：
D O I：
10.1016/j.dld.2015.01.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-14
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [21] Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
    Xia, Weiliang
    Ke, Qinghong
    Wang, Ye
    Wang, Weilin
    Zhang, Min
    Shen, Yan
    Wu, Jian
    Xu, Xiao
    Zheng, Shusen
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [22] Pre-Transplant HBV Viral Resistance Is Not a Risk Factor for HBV Recurrence after Liver Transplantation.
    Hu, Tsung-Hui
    Chen, Chao-Lung
    Wang, Chih-Chi
    Chiu, King-Wah
    Eng, Hock-Liew
    Cheng, Yu-Fan
    LIVER TRANSPLANTATION, 2012, 18 : S174 - S174
  • [23] Incidence and Pre-Transplant Risk Factors of Hepatocellular Carcinoma Recurrence after Liver Transplantation in MELD Era
    Sharma, Pratima
    Pelletier, Shawn
    Hussain, Hero
    Fontana, Robert
    Marrero, Jorge
    Merion, Robert
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 451 - 451
  • [24] Predictive value of pre-transplant platelet to lymphocyte ratio for hepatocellular carcinoma recurrence after liver transplantation
    Weiliang Xia
    Qinghong Ke
    Ye Wang
    Weilin Wang
    Min Zhang
    Yan Shen
    Jian Wu
    Xiao Xu
    Shusen Zheng
    World Journal of Surgical Oncology, 13
  • [25] Treatment of HCV-recurrence after liver transplantation with sofosbuvir/ledipasvir: the role of ribavirin
    Eurich, Dennis
    Globke, Brigitta
    Nathanael, Raschzok
    Teegen, Eva
    Dimrah, Iman
    Schott, Eckart
    Pratschke, Johann
    TRANSPLANTATION, 2016, 100 (07) : S274 - S274
  • [26] SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE
    Martini, Silvia
    Strona, Silvia
    Sacco, Marco
    Arese, Daniele
    Romagnoli, Renato
    Tandoi, Francesco
    Cocchis, Donatella
    Mirabella, Stefano
    Rizza, Giorgia
    Ottobrelli, Antonio
    Torrani, Cerenzia Maria Rosaria
    Balzola, Federico
    Salizzoni, Mauro
    Rizzetto, Mario
    TRANSPLANT INTERNATIONAL, 2015, 28 : 21 - 21
  • [27] Pre-Transplant Sarcopenia Does Not Reverse After Successful Liver Transplantation
    Patel, Trushar
    Vilchez, Valery
    Gedaly, Roberto
    Nair, Rashmi T.
    Dela Cruz, Anna Christina
    Barrett, Terrence
    HEPATOLOGY, 2015, 62 : 835A - 835A
  • [28] PRE-TRANSPLANT PARAMETERS PREDICT SURVIVAL DURING AND AFTER LIVER TRANSPLANTATION
    Garritsen, Rhiana
    Tien Nguyen
    Metselaar, Herold J.
    Tilanus, Hugo W.
    Kazemier, Geert
    TRANSPLANT INTERNATIONAL, 2011, 24 : 144 - 144
  • [29] THE COST-EFFECTIVENESS OF SOFOSBUVIR- AND SIMEPREVIR-BASED THERAPIES FOR HCV GENOTYPE 1 INFECTION
    Linas, B. P.
    Morgan, J. R.
    Pho, M. T.
    Leff, J. A.
    Schackman, B. R.
    Assoumou, S. A.
    Salomon, J. A.
    Freedberg, K. A.
    Kim, A. Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S633 - S633
  • [30] Pre-Transplant Parameters Predict Survival during and after Liver Transplantation
    Garritsen, Rhiana
    Nguyen, Tien D.
    Metselaar, Herold J.
    Tilanus, Hugo W.
    Kazemier, Geert
    LIVER TRANSPLANTATION, 2011, 17 (06) : S166 - S166
12345